{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:39:10Z","timestamp":1779892750853,"version":"3.53.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2014,5,18]],"date-time":"2014-05-18T00:00:00Z","timestamp":1400371200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s10620-014-3198-z","type":"journal-article","created":{"date-parts":[[2014,5,17]],"date-time":"2014-05-17T06:55:13Z","timestamp":1400309713000},"page":"2529-2535","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Mucosal Healing Predicts the Long-Term Prognosis of Intestinal Beh\u00e7et\u2019s Disease"],"prefix":"10.1007","volume":"59","author":[{"given":"Sun Mie","family":"Yim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duk Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Won","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Jung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Pil","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hee","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,18]]},"reference":[{"key":"3198_CR1","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJM197908233010811","volume":"301","author":"DG James","year":"1979","unstructured":"James DG. Behcet\u2019s syndrome. N Engl J Med. 1979;301:431\u2013432.","journal-title":"N Engl J Med"},{"key":"3198_CR2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0049-0172(98)80001-2","volume":"27","author":"VG Kaklamani","year":"1998","unstructured":"Kaklamani VG, Vaiopoulos G, Kaklamanis PG. Behcet\u2019s disease. Semin Arthritis Rheum. 1998;27:197\u2013217.","journal-title":"Semin Arthritis Rheum"},{"key":"3198_CR3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF02604297","volume":"24","author":"Y Kasahara","year":"1981","unstructured":"Kasahara Y, Tanaka S, Nishino M, et al. Intestinal involvement in Behcet\u2019s disease: review of 136 surgical cases in the Japanese literature. Dis Colon Rectum. 1981;24:103\u2013106.","journal-title":"Dis Colon Rectum"},{"key":"3198_CR4","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/BF02590829","volume":"19","author":"S Baba","year":"1976","unstructured":"Baba S, Maruta M, Ando K, et al. Intestinal Behcet\u2019s disease: report of five cases. Dis Colon Rectum. 1976;19:428\u2013440.","journal-title":"Dis Colon Rectum"},{"key":"3198_CR5","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00004836-200003000-00006","volume":"30","author":"Y Bayraktar","year":"2000","unstructured":"Bayraktar Y, Ozaslan E, Van Thiel DH. Gastrointestinal manifestations of Behcet\u2019s disease. J Clin Gastroenterol. 2000;30:144\u2013154.","journal-title":"J Clin Gastroenterol"},{"key":"3198_CR6","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"T Sakane","year":"1999","unstructured":"Sakane T, Takeno M, Suzuki N, et al. Behcet\u2019s disease. N Engl J Med. 1999;341:1284\u20131291.","journal-title":"N Engl J Med"},{"key":"3198_CR7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10620-008-0337-4","volume":"54","author":"EC Ebert","year":"2009","unstructured":"Ebert EC. Gastrointestinal manifestations of Behcet\u2019s disease. Dig Dis Sci. 2009;54:201\u2013207.","journal-title":"Dig Dis Sci"},{"key":"3198_CR8","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/ibd.20927","volume":"15","author":"F Schnitzler","year":"2009","unstructured":"Schnitzler F, Fidder H, Ferrante M, et al. Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn\u2019s disease. Inflamm Bowel Dis. 2009;15:1295\u20131301.","journal-title":"Inflamm Bowel Dis"},{"key":"3198_CR9","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1053\/j.gastro.2011.06.054","volume":"141","author":"JF Colombel","year":"2011","unstructured":"Colombel JF, Rutgeerts P, Reinisch W, et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology. 2011;141:1194\u20131201.","journal-title":"Gastroenterology"},{"key":"3198_CR10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.gie.2005.08.011","volume":"63","author":"P Rutgeerts","year":"2006","unstructured":"Rutgeerts P, Diamond RH, Bala M, et al. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn\u2019s disease. Gastrointest Endosc. 2006;63:433\u2013442.; quiz 464.","journal-title":"Gastrointest Endosc"},{"key":"3198_CR11","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.3748\/wjg.v16.i21.2626","volume":"16","author":"M Allez","year":"2010","unstructured":"Allez M, Lemann M. Role of endoscopy in predicting the disease course in inflammatory bowel disease. World J Gastroenterol. 2010;16:2626\u20132632.","journal-title":"World J Gastroenterol"},{"key":"3198_CR12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2174\/138945010790309902","volume":"11","author":"G Assche van","year":"2010","unstructured":"van Assche G, Vermeire S, Rutgeerts P. Mucosal healing and anti TNFs in IBD. Curr Drug Targets. 2010;11:227\u2013233.","journal-title":"Curr Drug Targets"},{"key":"3198_CR13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.5009\/gnl.2007.1.2.118","volume":"1","author":"JH Cheon","year":"2007","unstructured":"Cheon JH, Kim WH. Recent advances of endoscopy in inflammatory bowel diseases. Gut Liver. 2007;1:118\u2013125.","journal-title":"Gut Liver"},{"key":"3198_CR14","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1038\/ajg.2009.331","volume":"104","author":"JH Cheon","year":"2009","unstructured":"Cheon JH, Kim ES, Shin SJ, et al. Development and validation of novel diagnostic criteria for intestinal Behcet\u2019s disease in Korean patients with ileocolonic ulcers. Am J Gastroenterol. 2009;104:2492\u20132499.","journal-title":"Am J Gastroenterol"},{"key":"3198_CR15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00054725-200108000-00010","volume":"7","author":"CR Lee","year":"2001","unstructured":"Lee CR, Kim WH, Cho YS, et al. Colonoscopic findings in intestinal Behcet\u2019s disease. Inflamm Bowel Dis. 2001;7:243\u2013249.","journal-title":"Inflamm Bowel Dis"},{"key":"3198_CR16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/ibd.21313","volume":"17","author":"JH Cheon","year":"2011","unstructured":"Cheon JH, Han DS, Park JY, et al. Development, validation, and responsiveness of a novel disease activity index for intestinal Behcet\u2019s disease. Inflamm Bowel Dis. 2011;17:605\u2013613.","journal-title":"Inflamm Bowel Dis"},{"key":"3198_CR17","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1055\/s-2000-9012","volume":"32","author":"JS Kim","year":"2000","unstructured":"Kim JS, Lim SH, Choi IJ, et al. Prediction of the clinical course of Behcet\u2019s colitis according to macroscopic classification by colonoscopy. Endoscopy. 2000;32:635\u2013640.","journal-title":"Endoscopy"},{"key":"3198_CR18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrgastro.2009.203","volume":"7","author":"G Pineton de Chambrun","year":"2010","unstructured":"Pineton de Chambrun G, Peyrin-Biroulet L, Lemann M, et al. Clinical implications of mucosal healing for the management of IBD. Nat Rev Gastroenterol Hepatol. 2010;7:15\u201329.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3198_CR19","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.gastro.2006.12.038","volume":"132","author":"G D\u2019Haens","year":"2007","unstructured":"D\u2019Haens G, Sandborn WJ, Feagan BG, et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology. 2007;132:763\u2013786.","journal-title":"Gastroenterology"},{"key":"3198_CR20","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/ibd.21034","volume":"15","author":"GR D\u2019Haens","year":"2009","unstructured":"D\u2019Haens GR, Fedorak R, Lemann M, et al. Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn\u2019s disease. Inflamm Bowel Dis. 2009;15:1599\u20131604.","journal-title":"Inflamm Bowel Dis"},{"key":"3198_CR21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5217\/ir.2013.11.3.155","volume":"11","author":"HW Lee","year":"2013","unstructured":"Lee HW, Kim WH, Cheon JH. The medical treatments of intestinal Beh\u00e7et\u2019s disease: an update. Intest Res. 2013;11:155\u2013160.","journal-title":"Intest Res"},{"key":"3198_CR22","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/j.gastro.2012.01.035","volume":"142","author":"P Rutgeerts","year":"2012","unstructured":"Rutgeerts P, Van Assche G, Sandborn WJ, et al. Adalimumab induces and maintains mucosal healing in patients with Crohn\u2019s disease: data from the EXTEND trial. Gastroenterology. 2012;142:1102\u20131111. e1102.","journal-title":"Gastroenterology"},{"key":"3198_CR23","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","volume":"353","author":"P Rutgeerts","year":"2005","unstructured":"Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005;353:2462\u20132476.","journal-title":"N Engl J Med"},{"key":"3198_CR24","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","volume":"362","author":"JF Colombel","year":"2010","unstructured":"Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn\u2019s disease. N Engl J Med. 2010;362:1383\u20131395.","journal-title":"N Engl J Med"},{"key":"3198_CR25","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/ibd.21925","volume":"18","author":"JE Baars","year":"2012","unstructured":"Baars JE, Nuij VJ, Oldenburg B, et al. Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation. Inflamm Bowel Dis. 2012;18:1634\u20131640.","journal-title":"Inflamm Bowel Dis"},{"key":"3198_CR26","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ibd.20777","volume":"15","author":"GJ Mantzaris","year":"2009","unstructured":"Mantzaris GJ, Christidou A, Sfakianakis M, et al. Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn\u2019s disease. Inflamm Bowel Dis. 2009;15:375\u2013382.","journal-title":"Inflamm Bowel Dis"},{"key":"3198_CR27","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0016-5107(99)80017-0","volume":"50","author":"G D\u2019Haens","year":"1999","unstructured":"D\u2019Haens G, Geboes K, Rutgeerts P. Endoscopic and histologic healing of Crohn\u2019s (ileo-) colitis with azathioprine. Gastrointest Endosc. 1999;50:667\u2013671.","journal-title":"Gastrointest Endosc"},{"key":"3198_CR28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/gut.2005.068809","volume":"55","author":"S Ardizzone","year":"2006","unstructured":"Ardizzone S, Maconi G, Russo A, et al. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut. 2006;55:47\u201353.","journal-title":"Gut"},{"key":"3198_CR29","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1136\/gutjnl-2012-302830","volume":"61","author":"MF Neurath","year":"2012","unstructured":"Neurath MF, Travis SP. Mucosal healing in inflammatory bowel diseases: a systematic review. Gut. 2012;61:1619\u20131635.","journal-title":"Gut"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-014-3198-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-014-3198-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-014-3198-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T19:44:15Z","timestamp":1559245455000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-014-3198-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,18]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["3198"],"URL":"https:\/\/doi.org\/10.1007\/s10620-014-3198-z","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,18]]}}}